|
Type 1 diabetes
Citations 81-90 of 113 total displayed.
|
Past content
(since Mar 2001):
|
- Basic Science Reports
Irbesartan but Not Amlodipine Suppresses Diabetes-Associated Atherosclerosis
- Riccardo Candido, Terri J. Allen, Markus Lassila, Zemin Cao, Vicki Thallas, Mark E. Cooper, and Karin A. Jandeleit-Dahm
Circulation 2004;109:1536-1542; published online before print as doi:10.1161/01.CIR.0000124061.78478.94
[Abstract]
[Full text]
- Clinical Investigations and Reports
Clinical, Angiographic, and Procedural Predictors of Angiographic Restenosis After Sirolimus-Eluting Stent Implantation in Complex Patients: An Evaluation From the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Study
- Pedro A. Lemos, Angela Hoye, Dick Goedhart, Chourmouzios A. Arampatzis, Francesco Saia, Willem J. van der Giessen, Eugene McFadden, Georgios Sianos, Pieter C. Smits, Sjoerd H. Hofma, Pim J. de Feyter, Ron T. van Domburg, and Patrick W. Serruys
Circulation 2004;109:1366-1370; published online before print as doi:10.1161/01.CIR.0000121358.26097.06
[Abstract]
[Full text]
- Articles
Irbesartan but Not Amlodipine Suppresses Diabetes-Associated Atherosclerosis
- Riccardo Candido, Terri J. Allen, Markus Lassila, Zemin Cao, Vicki Thallas, Mark E. Cooper, and Karin A. Jandeleit-Dahm
Circulation published March 15, 2004, doi:10.1161/01.CIR.0000124061.78478.94
[Abstract]
- Articles
Endothelial Dysfunction and Increased Arterial Intima-Media Thickness in Children With Type 1 Diabetes
- Mikko J. Järvisalo, Maria Raitakari, Jyri O. Toikka, Anne Putto-Laurila, Riikka Rontu, Seppo Laine, Terho Lehtimäki, Tapani Rönnemaa, Jorma Viikari, and Olli T. Raitakari
Circulation published March 15, 2004, doi:10.1161/01.CIR.0000124725.46165.2C
[Abstract]
- Articles
Clinical, Angiographic, and Procedural Predictors of Angiographic Restenosis After Sirolimus-Eluting Stent Implantation in Complex Patients. An Evaluation From the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Study
- Pedro A. Lemos, Angela Hoye, Dick Goedhart, Chourmouzios A. Arampatzis, Francesco Saia, Willem J. van der Giessen, Eugene McFadden, Georgios Sianos, Pieter C. Smits, Sjoerd H. Hofma, Pim J. de Feyter, Ron T. van Domburg, and Patrick W. Serruys
Circulation published March 1, 2004, doi:10.1161/01.CIR.0000121358.26097.06
[Abstract]
- Review: Clinical Cardiology: New Frontiers
Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part II
- Thomas F. Lüscher, Mark A. Creager, Joshua A. Beckman, and Francesco Cosentino
Circulation 2003;108:1655-1661, doi:10.1161/01.CIR.0000089189.70578.E2
[Full text]
- Review: Clinical Cardiology: New Frontiers
Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part I
- Mark A. Creager, Thomas F. Lüscher, Francesco Cosentino, and Joshua A. Beckman
Circulation 2003;108:1527-1532, doi:10.1161/01.CIR.0000091257.27563.32
[Full text]
- Correspondence
Glitazones and Heart Failure: Critical Appraisal for the Clinician
- John B. Buse
Circulation 2003;108:e57, doi:10.1161/01.CIR.0000086929.95459.97
[Full text]
- Basic Science Reports
Diabetes-Induced Oxidative Stress and Low-Grade Inflammation in Porcine Coronary Arteries
- LiFeng Zhang, Andrew Zalewski, Yuchuan Liu, Tomasz Mazurek, Scott Cowan, Jack L. Martin, Susanna M. Hofmann, Helen Vlassara, and Yi Shi
Circulation 2003;108:472-478; published online before print as doi:10.1161/01.CIR.0000080378.96063.23
[Abstract]
[Full text]
- Cardiology Patient Pages
What Is an Angiotensin Converting Enzyme Inhibitor?
- Nancy K. Sweitzer
Circulation 2003;108:e16-18e, doi:10.1161/01.CIR.0000075957.16003.07
[Full text]
|
|
